Navigation Links
Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010
Date:9/16/2010

NEW BRUNSWICK, N.J., Sept. 15 /PRNewswire/ -- On Sept. 23 and 24, the Hyatt Regency in New Brunswick, N.J. will host Contracting & Outsourcing 2010, the 9th annual Conference and Tabletop Exhibition held by Contract Pharma Magazine. This year's Conference will feature a keynote presentation by Mac Lynch, Vice President, Contract Manufacturing at Pfizer, covering Global Pharma Outsourcing Trends. Other speakers and panelists represent FDA, Johnson & Johnson, Roche/Genentech, Bristol-Myers Squibb, Merck, GlaxoSmithKline and more.

Contracting & Outsourcing 2010 will feature presentations and panels discussing a wide array of pharma and biopharma outsourcing and contract service topics, including far east outsourcing, sponsor-provider partnerships, CMO management, FDA compliance enforcement, clinical trial management, inspection issues and more. The conference will also include a panel on Contract Laboratory Criteria and the inaugural Executive Outsourcing Summit, with participants from across the drug development spectrum.

The event will feature a one-day Tabletop Exhibition on Sept. 23. With 160 contract service providers and vendors in attendance, the Exhibit Hall will cover virtually every aspect of the drug development and commercialization continuum.

Networking opportunities are enhanced by a Cocktail Reception at the end of the first day. Sponsored by Catalent Pharma Solutions, the reception offers an informal atmosphere for conversation and deal-making. The mix of presentations and exhibitions promises value to attendees from large pharma and biopharma companies as well as those from emerging and startup firms.

A full list of exhibitors can be found at http://contractpharma.com/2010conference/exhibitor_list

The schedule for Contracting & Outsourcing, as well as bios of all speakers, can be found at http://contractpharma.com/2010conference/speakers_and_topics

Attendee registration costs $395 and covers all conference and exhibit hall  sessions, lunch, refreshment breaks, and the Networking Reception. Registration is available online at http://regonline.com/cpa10 or by walkup at the Hyatt Regency in New Brunswick, NJ.

Now in its ninth year, Contracting & Outsourcing is the premier event for pharma and biopharma contract services and outsourcing.

For additional information about Contracting & Outsourcing 2010, visit http://contractpharma.com/2010conference or contact Kristin Brooks at +1-201-880-2226 or kbrooks@rodpub.com. For more about Contract Pharma, the top magazine worldwide for pharma and biopharma contract services and outsourcing, visit http://contractpharma.com


'/>"/>
SOURCE Contract Pharma Magazine
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. WWMR Announces Pain Clinic Physicians Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals
2. Lakewood-Amedex, Inc. Appoints William J. Robison, Former Executive Vice President of Pfizer, as Board Member
3. Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors
4. Neuralstem CEO to Speak on ALS Panel at World Stem Cell Summit
5. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
6. MedNet Solutions to Speak, Sponsor and Exhibit at the 2008 Society of Clinical Data Management Annual Conference in Dallas
7. Former Speaker of the House Newt Gingrich Featured Wednesday
8. Brain and Hearing Pioneer, Michael Merzenich, Ph.D. to Speak at Case Western Reserve University
9. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
10. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
11. Varian, Inc. CEO to Speak at the Nasdaq OMX 22nd Investor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of ... their brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been ... Target to its list of well-respected retailers. This list includes such fine stores ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
Breaking Biology News(10 mins):